TAVLESSE

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug TAVLESSE contains one active pharmaceutical ingredient (API):

1 Fostamatinib disodium hexahydrate
UNII 86EEZ49YVB - FOSTAMATINIB DISODIUM

Fostamatinib mediates its activity effectively through its major metabolite, R406, which is a tyrosine kinase inhibitor with demonstrated activity against spleen tyrosine kinase (SYK). R406 inhibits signal transduction of B-cell receptors and Fc-activating receptors, which play a key role in antibody-mediated cellular responses. The fostamatinib metabolite R406 reduces antibody-mediated destruction of platelets.

Read about Fostamatinib

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TAVLESSE Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BX09 B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics
Discover more medicines within B02BX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1809480, 1809491, 1809503, 1809514
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1191405001, 1191405002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 132187, 192372
Country: FR Base de données publique des médicaments Identifier(s): 62637153, 65212047
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 387056, 387058
Country: IT Agenzia del Farmaco Identifier(s): 048441012, 048441024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1089186, 1089187
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100429958, 100429964

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.